Collegium Pharmaceutical, Inc. · NASDAQ:COLL
Glancy Donovan Michael received 17,482 Collegium Pharmaceutical, Inc. shares as an award (Form 4)
Traded May 14, 2026 · Filed May 18, 2026
On May 14, 2026, Glancy Donovan Michael (Director) received 17,482 Collegium Pharmaceutical, Inc. shares as an award, leaving 17,482 shares. Filed May 18, 2026 (Form 4).
- Awarded
- 17,482 shares
- Holding after
- 17,482 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Award | 17,482 | 17,482 | Direct |
Source
Related
- Collegium Pharmaceutical, Inc.
- Glancy Donovan Michael
- Collegium Pharmaceutical, Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Schedule 13G · Fuller & Thaler Asset Management, Inc. · Aug 14, 2026
- Schedule 13G · Principal Global Investors · Aug 5, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026